Live Breaking News & Updates on Insider Activity At Agios Pharmaceuticals

Stay updated with breaking news from Insider activity at agios pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year High at $39.70

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $39.70 and last traded at $38.91, with a volume of 573087 shares changing hands. The stock had previously closed at $31.50. Wall Street Analysts Forecast Growth A number of equities analysts have recently […] ....

United States , James William Burns , Jacqualyna Fouse , News Ratings For Agios Pharmaceuticals Daily , Securities Exchange Commission , Agios Pharmaceuticals Inc , Cantor Fitzgerald , Insider Activity At Agios Pharmaceuticals , Institutional Investors Weigh In On Agios Pharmaceuticals , Farallon Capital Management , Jpmorgan Chase Co , Pricet Rowe Associates Inc , Agios Pharmaceuticals , Tidal Investments , Kennedy Capital Management , Agios Pharmaceuticals Company Profile , Goldman Sachs Group , Caxton Associates , Royal Bank , Agios Pharmaceuticals Price Performance , Get Free Report , Director Jacqualyn , Exchange Commission , Capital Management , Pricet Rowe Associates , Agios Pharmaceuticals Daily ,

The Goldman Sachs Group Boosts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00

The Goldman Sachs Group Boosts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , James William Burns , Jacqualyna Fouse , Jpmorgan Chase Co , News Ratings For Agios Pharmaceuticals Daily , Agios Pharmaceuticals , China Universal Asset Management Co , Charles Schwab Investment Management Inc , Deutsche Bank , Royal Bank , Mirae Asset Global Investments Co , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals Inc , Cantor Fitzgerald , Insider Activity At Agios Pharmaceuticals , Goldman Sachs Group , Free Report , Get Free Report , Director Jacqualyn , Schwab Investment Management , Universal Asset Management , Asset Global Investments , Agios Pharmaceuticals Daily ,

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Earnings Results, Beats Estimates By $0.19 EPS

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.45) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.64) by $0.19, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 38.08% and a negative net margin of 1,312.64%. The company had […] ....

United States , Brian Goff , James William Burns , Insider Activity At Agios Pharmaceuticals , Goldman Sachs Group , Cantor Fitzgerald , Agios Pharmaceuticals Trading Down , Jpmorgan Chase Co , Royal Bank , Securities Exchange Commission , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , News Ratings For Agios Pharmaceuticals Daily , Earnings History For Agios Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , Exchange Commission , Agios Pharmaceuticals Daily , Nasdaq Agio ,

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.45) EPS for the quarter, topping analysts’ consensus estimates of ($1.64) by $0.19, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 38.08% and a negative net margin of 1,312.64%. The company had revenue of […] ....

United States , Brian Goff , James William Burns , Agios Pharmaceuticals , Agios Pharmaceuticals Inc , Royal Bank , Earnings History For Agios Pharmaceuticals , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals Company Profile , Insider Activity At Agios Pharmaceuticals , Goldman Sachs Group , Cantor Fitzgerald , News Ratings For Agios Pharmaceuticals Daily , Jpmorgan Chase Co , Get Free Report , Agios Pharmaceuticals Daily , Nasdaq Agio ,

Profund Advisors LLC Has $572,000 Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Profund Advisors LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 23.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,116 shares of the biopharmaceutical company’s stock after selling 7,028 shares during the quarter. Profund […] ....

Hong Kong , Tsveta Milanova , Brian Goff , China Universal Asset Management Co , Agios Pharmaceuticals , Agios Pharmaceuticals Profile , Royal Bank , Tower Research Capital , Quarter For Agios Pharmaceuticals , Agios Pharmaceuticals Inc , Cantor Fitzgerald , News Ratings For Agios Pharmaceuticals Daily , Goldman Sachs Group , Exchange Commission , Lazard Asset Management , Agios Pharmaceuticals Stock Down , Jpmorgan Chase Co , Profund Advisors , Insider Activity At Agios Pharmaceuticals , Hong Kong Ltd , Ameritas Investment Partners Inc , Free Report , Universal Asset Management , Kong Ltd , Research Capital , Asset Management ,